Greg Thurber

Greg M. Thurber is Associate Professor of Chemical Engineering and Biomedical Engineering at the University of Michigan. His work focuses on applying fundamental biotransport principles to design novel therapeutics and molecular imaging agents. These widely applicable techniques have found use in the Thurber laboratory in diverse projects ranging from self-administration of near-infrared molecular imaging agents for early disease detection to the modular design of stabilized alpha helices using bioorthogonal chemistry. The concepts for monoclonal antibodies and small molecule payloads have found application in designing improved antibody-drug conjugates for cancer therapy. Prof. Thurber received his training in protein therapeutics at MIT under the guidance of Dr. Dane Wittrup. He completed his in vivo training in molecular imaging in the laboratory of Dr. Ralph Weissleder at Mass General Hospital and Harvard Medical School. During his career, he has delivered over 50 invited talks at major pharmaceutical companies, national and international conferences, and university departmental seminars. He also has consulting/research contract affiliations with more than 15 different companies. Prof. Thurber has authored 40+ peer-reviewed journal publications, 3 book chapters, numerous conference proceedings, and his work has been featured in popular news outlets including NPR’s “All Things Considered” and Smithsonian Magazine. He has received several awards including an NIH K01 award and the National Science Foundation CAREER award